What happened with AIP today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Arteris supplies chipmakers and companies designing electronic systems with reusable designs that move data between processors, memory and other components inside complex chips. Its interconnect technology, including FlexNoC, links these components; its SoC Integration Automation software helps customers configure those connections and assemble the components into a system-on-chip.
Customers pay to license the technology and software, with licensing, support and maintenance providing most revenue. A smaller stream comes from royalties when customers sell chips containing Arteris technology, calculated per unit or as a share of product revenue. The business depends on customers choosing its technology during design and bringing those products to volume production. Long development cycles mean royalties can arrive years after a design is selected, and some projects never generate them. Revenue is concentrated among a small number of customers.
U.S. export controls already restrict Arteris’s ability to license or support products for certain China-related advanced-AI and supercomputer businesses. FlexNoC also relies on rights retained or licensed under agreements with Qualcomm. Those agreements restrict transfer of the license and allow termination under specified conditions; certain changes of control could end access to a development environment used to enhance FlexNoC.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Arteris depends on customers’ chip-design spending and chip shipments, making Synopsys, an important IP and design-tool ecosystem participant, and Samsung Electronics, an identified key customer, worth watching beyond this list.
Arm competes with Arteris to supply designs that connect chip components, but also licenses processor designs that customers combine with Arteris interconnects. Both collect fees from chip designers and royalties on chips using their IP, so Arm’s licensing and royalty revenue offer a read on new designs and chip shipments, not just competitive pressure.
CEVA and Arteris share exposure to chip designers’ spending on licensed technology: CEVA supplies processors and software, while Arteris supplies connections between chip components. Their IP serves complementary roles in automotive, industrial, consumer and computing chips, making CEVA’s customer demand in those markets a useful signal for Arteris.
Cadence and Arteris draw revenue from the same customers’ chip-design work: Cadence sells design and verification tools and reusable chip designs, while Arteris supplies connections between chip components and software to assemble them. Demand for Cadence’s chip-design tools and silicon IP is therefore worth watching for clues to the design spending that supports Arteris.
Rambus and Arteris both address spending on complex chips that need to move data efficiently: Rambus supplies digital controller and data-security designs to chip developers, while Arteris supplies the connections that carry data between chip components. Watch demand for Rambus’s controller IP used in accelerated-computing chips, rather than treating all its memory-chip sales as a signal for Arteris.
Texas Instruments is a key paying customer for Arteris’s chip-design IP and support, and its sales of chips incorporating Arteris IP generate royalties for Arteris. Texas Instruments sells semiconductors to electronics designers and manufacturers; disruptions to development or sales of its Arteris-licensed chips, including litigation, can reduce those royalties.
Arteris relies on rights and technology licensed by Qualcomm at no charge to keep offering and supporting certain FlexNoC products that connect chip components. Watch any change of control at Arteris: under specified conditions, Qualcomm can terminate access to a FlexNoC development environment, potentially preventing further product enhancements.
Texas Instruments Incorporated earningsTXN
Texas Instruments’ report will show whether sales of its chips using Arteris IP are generating royalties for Arteris, or whether development and shipment disruptions are holding them back.
Look at Texas Instruments’ chip sales and any reported development or shipment disruption. Stronger sales with programs moving ahead mean more opportunity for chips using Arteris IP to ship and generate royalties, calculated per unit or as a share of product revenue. Weaker sales or delays can reduce those royalties even while design licenses remain in place.
Arteris, Inc. earningsThis company
Arteris sells chip-interconnect licenses and software, then collects royalties when customers ship chips using its IP; this report shows whether design adoption is turning into revenue while costs still exceed it.
Read license, support and maintenance revenue alongside royalties: growth in the first points to more customer licensing, while growth in the second means more revenue from shipments of chips using Arteris IP. Strength in both would show designs moving from contracts toward production. Then compare gross profit with operating expenses: if gross profit grows faster, losses have a path to narrow; if expenses still outweigh the added revenue, growth has not yet brought profitability closer.
